Trial intelligence / Profile preview

Ozone Therapy for Pain in Diabetic Neuropathy

NCT05000463Unknown

Sponsor
Assiut University
Start
Feb 2022
Primary completion
Aug 2022
Modality
Inhalation Devices
Countries
1
01

Overview

Randomised, open-label trial of medical ozonated water in diabetic neuropathy (2 arms), sponsored by Assiut University. Primary endpoint: Pain Assessment at 6 months. Status: unknown.

02

Drugs

medical ozonated water
03

Conditions

diabetic neuropathy

Beyond the preview

Go deeper on NCT05000463.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05000463.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call